Positron emission tomography in the staging of small-cell lung cancer - A preliminary study

被引:51
作者
Hauber, HP
Bohuslavizki, KH
Lund, CH
Fritscher-Ravens, A
Meyer, A
Pforte, A
机构
[1] Univ Hamburg, Hosp Eppendorf, Dept Internal Med, D-20246 Hamburg, Germany
[2] Univ Hamburg, Hosp Eppendorf, Dept Nucl Med, D-20246 Hamburg, Germany
[3] Univ Hamburg, Hosp Eppendorf, Dept Radiol, D-20246 Hamburg, Germany
[4] Univ Hamburg, Hosp Eppendorf, Dept Endoscopy, D-20246 Hamburg, Germany
关键词
extensive disease; limited disease; metastases; positron emission tomography; prognosis; small-cell lung cancer; staging;
D O I
10.1378/chest.119.3.950
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Small-cell lung cancer (SCLC) has an unfavorable prognosis, especially when the disease is extensive at presentation, Accurate staging procedures are therefore needed for treatment planning, Positron emission tomography (PET) is a modern noninvasive imaging technique, the value of which for the staging of SCLC was investigated in the present study. Setting: University hospital. Patients: Thirty-one patients with suspected lung cancer were investigated for staging purposes using chest radiography, CT of the thorax and abdomen, abdominal ultrasound, and bone scanning. Twenty-five patients also received PET examinations during the staging procedures. Five of these patients were found to have SCLC, while two patients had mixed lesion types. Further analysis of the latter group was carried out. Results: PET detected the primary tumor in all patients, and lymph nodes in five patients, All lymph nodes were proved to be malignant by endoscopic ultrasonography-guided fine-needle aspiration. Only one patient had distant metastases, which vr ere detected by both CT and PET. Conclusions: PET appears be a suitable imaging method in SCLC. A potential role for the technique as a standard staging procedure will need to be tested by investigating a larger number of patients in a prospective study.
引用
收藏
页码:950 / 954
页数:5
相关论文
共 31 条
[1]   Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography [J].
Bury, T ;
Dowlati, A ;
Paulus, P ;
Hustinx, R ;
Radermecker, M ;
Rigo, P .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (02) :204-206
[2]   Staging of the mediastinum: Value of positron emission tomography imaging in non-small cell lung cancer [J].
Bury, T ;
Paulus, P ;
Dowlati, A ;
Corhay, JL ;
Weber, T ;
Ghaye, B ;
Schoffers, J ;
Limet, R ;
Albert, A ;
Rigo, P ;
Radermecker, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (12) :2560-2564
[3]   Evaluation of the solitary pulmonary nodule by positron emission tomography imaging [J].
Bury, T ;
Dowlati, A ;
Paulus, P ;
Corhay, JL ;
Benoit, T ;
Kayembe, JM ;
Limet, R ;
Rigo, P ;
Radermecker, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (03) :410-414
[4]  
DAHLBOM M, 1992, J NUCL MED, V33, P1191
[5]   Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer [J].
Fritscher-Ravens, A ;
Soehendra, N ;
Schirrow, L ;
Sriram, PVJ ;
Meyer, A ;
Hauber, HP ;
Pforte, A .
CHEST, 2000, 117 (02) :339-345
[6]   Lymph node staging in non-small cell lung cancer: Evaluation by [F-18]FDG positron emission tomography (PET) [J].
Guhlmann, A ;
Storck, M ;
Kotzerke, J ;
Moog, F ;
SunderPlassmann, L ;
Reske, SN .
THORAX, 1997, 52 (05) :438-441
[7]  
Gupta NC, 1996, J NUCL MED, V37, P943
[8]   Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer [J].
Gupta, NC ;
Graeber, GM ;
Rogers, JS ;
Bishop, HA .
ANNALS OF SURGERY, 1999, 229 (02) :286-291
[9]   Evaluation of pulmonary lesions with FDG-PET - Comparison of findings in patients with and without a history of prior malignancy [J].
Knight, SB ;
Delbeke, D ;
Stewart, JR ;
Sandler, MP ;
Ebers, T .
CHEST, 1996, 109 (04) :982-988
[10]   Bone marrow uptake of fluorine-18-fluorodeoxyglucose following treatment with hematopoietic growth factors: Initial evaluation [J].
Knopp, MV ;
Bischoff, H ;
Rimac, A ;
Oberdorfer, F ;
vanKaick, G .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06) :845-849